Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2026 Earnings Call November 4, 2026 5:00 PM ESTCompany ParticipantsDebra Hart - Senior Director of Inves...
Adamas Trust (NASDAQ:ADAM) Screens as a High-Growth Candidate With Improving Fundamentals
3 days agoAdamas Trust (ADAM) passes Little Book growth criteria on earnings revisions, sales, margins and cash flow, but balance-sheet and dividend risks remai...
Retail investors talked up 5 hot stocks during the week (Nov. 2 to Nov. 6) on X and Reddit's r/WallStreetBets: AMD, INTC, TSLA, NVDA, MU.
Amazon forecasts $220 billion in spending this year.
The Meta CEO and Priscilla Chan pledged 99% of their shares in a 2015 letter to their newborn. Those shares were worth $45 billion then; his fortune n...
AppLovin has delivered the rich, game-driven, ad revenue growth by >50% in the Q3'26 earnings season. Read why APP stock is a buy.
Not only are consumer prices rising, but two of President Trump’s policies are partly to blame.
1 Reason to Buy AMD Stock Before 2027
3 days agoAMD just guided to more than twice the growth it promised a year ago, and the stock still trades at about 20.5 times 2028 earnings estimates.
Remitly Global (NASDAQ:RELY): High Growth and Improving Fundamentals Check the Eight Rules
3 days agoRemitly passes most of Navellier’s eight growth-stock rules—strong earnings, cash flow and ROE—but profitability and dilution are caveats.
Franklin Covey (NYSE:FC) expects revenue and adjusted EBITDA to grow in fiscal 2027, as a rise in North American invoicing and deferred revenue flows ...
Eagle Materials (NYSE:EXP) reported record revenue for its fiscal 2027 second quarter, but higher diesel and freight costs weighed on earnings across ...
For questions about this article or underlying research, email [email protected].
For questions about this article or underlying research, email [email protected].
For questions about this article or underlying research, email [email protected].
For questions about this article or underlying research, email [email protected].
Edwards Lifesciences (NYSE:EW) raised its 2026 sales and earnings guidance after third-quarter results exceeded management’s expectations, with growth...
Evolent Health (NYSE:EVH) raised the lower end of its 2026 adjusted earnings outlook after third-quarter revenue and profitability improved from the p...
Loading...
